Todd Andrew
Todd Andrew Bachochin, Berlin Center, OH US
Patent application number | Description | Published |
---|---|---|
20110117229 | SEGMENTED TIRE MOLD - The present invention relates to an apparatus for providing the upper and lower portions of two-part tire molds with an expansible opening to provide clearance for the insertion of green tires, in particular large green tires of the sort used on industrial or off-road vehicles. The tire mold according to the present invention provides a segmented tire mold wherein a plurality of circumferentially arranged segments that contribute to the shaping of the circumferential tread portion of a tire being molded are able to move in such a way as to include a radial and axial component of motion that provides a larger diameter for each of the two mold portions during the green tire loading operation. Thus the internal circumferential region of the top portion and of the bottom portion is able to expand in diametrical dimension when the two part tire mold is open. | 05-19-2011 |
Todd Andrew Begalke, Roseville, MN US
Todd Andrew Brugel, Wilmington, DE US
Patent application number | Description | Published |
---|---|---|
20090030033 | Novel Compounds 894 - The invention relates to 2-aza-bicyclo[2.2.2]octane compounds and uses thereof. Particularly the invention relates to such compounds and their uses as pharmaceuticals in treating pyshoses such as schizophrenia and other diseases, disorders, or conditions. | 01-29-2009 |
20090076020 | Cyclopropyl Amide Derivatives 978 - Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith. | 03-19-2009 |
20120094995 | 2-AZA-BICYCLO[2.2.1]HEPTANE COMPOUNDS AND USES THEREOF - This invention relates to 2-aza-bicyclo[2.2.1]heptane compounds (and salts thereof), the process for making such a compound and pharmaceutical compositions comprising such a compound. The invention also relates to the use of the compounds for modulating the glycine transporter 1 (GlyT1) and for the treatment of psychosis, cognitive disorders, bipolar disorders, depression disorders, anxiety disorders, post-traumatic stress disorders and pain. | 04-19-2012 |
Todd Andrew Brugel, West Chester, OH US
Patent application number | Description | Published |
---|---|---|
20090069355 | Bicyclic pyrazolone cytokine inhibitors - The present invention relates to 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones which inhibit the extracellular release of inflammatory cytokines, said cytokines responsible for one or more human or higher mammalian disease states. The present invention further relates to compositions comprising said 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones and methods for preventing, abating, or otherwise controlling enzymes which are understood to be the active components responsible for the herein described disease states. | 03-12-2009 |